These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 16300419)
1. Effect of a clinical pharmacy education program on improvement in the quantity and quality of venous thromboembolism prophylaxis for medically ill patients. Dobesh PP; Stacy ZA J Manag Care Pharm; 2005; 11(9):755-62. PubMed ID: 16300419 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients. Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080 [TBL] [Abstract][Full Text] [Related]
3. Assessing, preventing, and treating venous thromboembolism: evidence-based approaches. Nutescu EA Am J Health Syst Pharm; 2007 Jun; 64(11 Suppl 7):S5-13. PubMed ID: 17519445 [TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism in medically ill patients: identifying risk and strategies for prevention. Wheeler A Clin Cornerstone; 2005; 7(4):23-31. PubMed ID: 16758649 [TBL] [Abstract][Full Text] [Related]
6. Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients. Spyropoulos AC Chest; 2005 Aug; 128(2):958-69. PubMed ID: 16100192 [TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280 [TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients. Rothberg MB; Pekow PS; Lahti M; Lindenauer PK J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry. Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679 [TBL] [Abstract][Full Text] [Related]
10. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group. Kakkar VV; Howes J; Sharma V; Kadziola Z Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310 [TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients. Haas S Semin Thromb Hemost; 1999; 25 Suppl 3():101-5. PubMed ID: 10549724 [TBL] [Abstract][Full Text] [Related]
12. Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study. Lacherade JC; Cook D; Heyland D; Chrusch C; Brochard L; Brun-Buisson C; J Crit Care; 2003 Dec; 18(4):228-37. PubMed ID: 14691896 [TBL] [Abstract][Full Text] [Related]
13. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Bain E; Wilson A; Tooher R; Gates S; Davis LJ; Middleton P Cochrane Database Syst Rev; 2014 Feb; (2):CD001689. PubMed ID: 24519568 [TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Tapson VF; Decousus H; Pini M; Chong BH; Froehlich JB; Monreal M; Spyropoulos AC; Merli GJ; Zotz RB; Bergmann JF; Pavanello R; Turpie AG; Nakamura M; Piovella F; Kakkar AK; Spencer FA; Fitzgerald G; Anderson FA; Chest; 2007 Sep; 132(3):936-45. PubMed ID: 17573514 [TBL] [Abstract][Full Text] [Related]
15. Development and implementation of a program to assess medical patients' need for venous thromboembolism prophylaxis. Sobieraj DM Am J Health Syst Pharm; 2008 Sep; 65(18):1755-60. PubMed ID: 18769004 [TBL] [Abstract][Full Text] [Related]
16. [Inadequacy of thromboprophylaxis in hospitalized medical patients]. Rocha AT; Braga P; Ritt G; Lopes AA Rev Assoc Med Bras (1992); 2006; 52(6):441-6. PubMed ID: 17242783 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims. Kociol RD; Hammill BG; Hernandez AF; Klaskala W; Mills RM; Curtis LH; Fonarow GC Clin Cardiol; 2011 Nov; 34(11):682-8. PubMed ID: 22057910 [TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism in the medically ill patient: a call to action. Bergmann JF; Kher A Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352 [TBL] [Abstract][Full Text] [Related]
19. The importance of appropriate prophylaxis for the prevention of venous thromboembolism in at-risk medical patients. Dobesh P Int J Clin Pract; 2010 Oct; 64(11):1554-1562. PubMed ID: 20846203 [TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism prophylaxis in the medically ill patient. Michota FA Clin Chest Med; 2003 Mar; 24(1):93-101. PubMed ID: 12685058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]